FDA approves Keytruda as treatment for specific type of esophageal cancer
The U.S. Food and Drug Administration (FDA) has approved a new treatment option for patients with advanced esophageal cancer — the immunotherapy drug pembrolizumab, known by its brand name “Keytruda.”…